Tuberculosis News and Research

Latest Tuberculosis News and Research

CHMP issues positive opinion supporting use of Trelegy Ellipta in broader group of COPD patients

GlaxoSmithKline plc and Innoviva, Inc. announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion today supporting the use of Trelegy Ellipta in a broader group of patients with moderate to severe chronic obstructive pulmonary disease and that labeling, if approved, will be updated to further reflect its effect on exacerbations of COPD.

21 Sep 2018

New naturally occurring antibiotic found effective against Mycobacterium tuberculosis

A naturally occurring antibiotic called kanglemycin A is effective against Mycobacterium tuberculosis, the bacteria that cause tuberculosis, even in drug-resistant strains, according to an international team of researchers who used chemistry, molecular biology, microbiology, and X-ray crystallography to show how the compound maintains its activity.

21 Sep 2018

LSTM partners with TB Alliance to develop novel TB drug regimens

LSTM and TB Alliance are collaborating to investigate novel combination drug therapies that could help the fight against multidrug-resistant tuberculosis (MDR-TB), following an award of £1 million from the Medical Research Council.

19 Sep 2018

QIAGEN and DiaSorin launch automated, CE-marked workflow for high-throughput TB screening

QIAGEN N.V. and DiaSorin today announced the introduction of an automated, CE-marked workflow for QIAGEN’s QuantiFERON-TB Gold Plus Blood Collection Tubes (QFT-Plus BCT) and a novel DiaSorin LIAISON Test on widely used immunodiagnostic instruments from DiaSorin.

17 Sep 2018

Inhaled steroid use linked to greater risk of NTM lung infections

Patients using inhaled steroids to control asthma and other breathing problems may be at greater risk for developing nontuberculous mycobacteria lung infections, according to new research published online in the Annals of the American Thoracic Society.

17 Sep 2018

Scientists develop first non-antibiotic drug to treat tuberculosis in animals

Scientists at The University of Manchester have developed the first non-antibiotic drug to successfully treat tuberculosis in animals.

11 Sep 2018

Effective vaccines for world's most prevalent infectious diseases are missing from pipeline

Many of the vaccines critically needed to fight some of the world's most prevalent infectious diseases are not likely to be developed, a new analysis of current candidates in the research and development pipeline has found.

5 Sep 2018

Study provides insights into how harmful white blood cells form during tuberculosis

Insights into how harmful white blood cells form during tuberculosis infection point to novel targets for pharmacological interventions, according to a study published in the open-access journal PLOS Pathogens by Valentina Guerrini and Maria Laura Gennaro of Rutgers New Jersey Medical School, and colleagues.

31 Aug 2018

Around 8.4 million deaths occur each year from poor quality of care in low- and middle-income countries

Recent gains against the burden of illness, injury, and disability and commitment to universal health coverage are insufficient to close the enormous gaps that remain between what is achievable in human health and where global health stands today, says a new report from the National Academies of Sciences, Engineering, and Medicine.

29 Aug 2018

New Cochrane Review assesses accuracy of Xpert in diagnosing extrapulmonary TB

In one-fifth of people with active tuberculosis, the site of disease is outside the lungs. Some forms of extrapulmonary TB, such as TB meningitis, are extremely dangerous, where a rapid diagnosis can make all the difference to a patient.

28 Aug 2018

TB Alliance initiates SimpliciTB to test if new four-drug regimen can treat most types of tuberculosis

TB Alliance has initiated a pivotal clinical trial, SimpliciTB, that will evaluate whether a new four-drug regimen can treat most types of tuberculosis including multidrug-resistant TB more quickly and effectively than currently-available treatments.

28 Aug 2018

New technique may provide continuous country-level surveillance of drug-resistant tuberculosis

Global tuberculosis control and elimination will require detailed real-time information on the location of individuals with the disease, the presence of drug resistance, and the patterns of transmission.

23 Aug 2018

Scientists gain new insight into the immune system and infections

Researchers from Sydney have found that the body contains a special structure that can act as front line soldiers in case of infections. These are the cells that could be the main agents in preserving vaccine-memory, they find.

22 Aug 2018

New method identifies communities experiencing drug-resistant tuberculosis in South Africa

Researchers at Boston Medical Center have created a near real-time surveillance method to identify communities experiencing a high burden of drug-resistant tuberculosis in South Africa using routinely collected laboratory data.

22 Aug 2018

Blood test could identify bladder cancer patients who may not benefit from immunotherapy

Patients who are unlikely to benefit from a commonly used immunotherapy for bladder cancer could be identified by a simple blood test, according to researchers at Brighton and Sussex Medical School.

21 Aug 2018

Children with multidrug-resistant tuberculosis have successful treatment outcomes, study shows

The results of a large, international systematic review published in the journal PLOS Medicine show that tuberculosis treatment is successful in children with multidrug-resistant tuberculosis. The study was used to inform the World Health Organization guidelines on treatment of MDR-TB in children.

21 Aug 2018

Researchers develop new approach to study how tuberculosis infects people

Tuberculosis is one of the top 10 causes of death worldwide. Nearly 2 million people die every year from this infectious disease, and an estimated 2 billion people are chronically infected.

17 Aug 2018

Researchers move closer to finding potential soft spot in drug-resistant tuberculosis

Antibiotic-resistant tuberculosis is a public health threat. TB and other bacteria become resistant to antibiotics by evolving genetic changes over time, which they can do quite quickly because bacterial lifecycles are short.

15 Aug 2018

Adolescent health projects receive meager percentage of global funding, study finds

Even though adolescents make up 26 percent of the population in developing countries, their health claimed a meager 1.6 percent of global development assistance between 2003 and 2016, according to a newly published study led by researchers at Harvard Medical School.

13 Aug 2018

Adolescent health programs receive only a tiny share of international aid, finds research

Melbourne's Murdoch Children's Research Institute, in partnership with Harvard Medical School, has discovered that adolescent health programs across the developing world receive only a tiny share of international aid, even though young people make up 30 percent of the population of low-income countries.

10 Aug 2018

Tuberculosis News and Research

Latest Tuberculosis News and Research

CHMP issues positive opinion supporting use of Trelegy Ellipta in broader group of COPD patients

New naturally occurring antibiotic found effective against Mycobacterium tuberculosis

LSTM partners with TB Alliance to develop novel TB drug regimens

QIAGEN and DiaSorin launch automated, CE-marked workflow for high-throughput TB screening

Inhaled steroid use linked to greater risk of NTM lung infections

Scientists develop first non-antibiotic drug to treat tuberculosis in animals

Effective vaccines for world's most prevalent infectious diseases are missing from pipeline

Study provides insights into how harmful white blood cells form during tuberculosis

Around 8.4 million deaths occur each year from poor quality of care in low- and middle-income countries

New Cochrane Review assesses accuracy of Xpert in diagnosing extrapulmonary TB

TB Alliance initiates SimpliciTB to test if new four-drug regimen can treat most types of tuberculosis

New technique may provide continuous country-level surveillance of drug-resistant tuberculosis

Scientists gain new insight into the immune system and infections

New method identifies communities experiencing drug-resistant tuberculosis in South Africa

Blood test could identify bladder cancer patients who may not benefit from immunotherapy

Children with multidrug-resistant tuberculosis have successful treatment outcomes, study shows

Researchers develop new approach to study how tuberculosis infects people

Researchers move closer to finding potential soft spot in drug-resistant tuberculosis

Adolescent health projects receive meager percentage of global funding, study finds

Adolescent health programs receive only a tiny share of international aid, finds research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Tuberculosis News and Research

Latest Tuberculosis News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in